LANGENFELD, Germany, July 31, 2019 /PRNewswire/ -- Neuraxpharm Group, a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, announces the launch of its first products in the United Kingdom. Neuraxpharm also announces the... |